TrademarkDir
MEKTOVI (BINIMETINIB)
DEAD

Serial Number

87059929

Owner

Array BioPharma Inc.

Attorney

Heather A. McDonald

First Use Date

Sep 21, 2017

Filing Date

Jun 3, 2016

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

MEKTOVI (BINIMETINIB) Trademark

Serial Number: 87059929 • Registration: 5381495

MEKTOVI (BINIMETINIB) is a trademark filed by Array BioPharma Inc. on June 3, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Array BioPharma Inc. (29 trademarks)

Boulder, CO 80301

Entity Type: 03

Trademark Details

Filing Date

June 3, 2016

Registration Date

January 16, 2018

First Use Anywhere

September 21, 2017

First Use in Commerce

September 21, 2017

Published for Opposition

April 4, 2017

Cancellation Date

July 26, 2024

Goods & Services

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer and tumors; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; all of the foregoing incorporating the inhibitor binimetinib

Filing History

CANCELLED SEC. 8 (6-YR)
Jul 26, 2024 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 16, 2023 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 4, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 4, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 4, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 4, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 4, 2020 COAR
REGISTERED-PRINCIPAL REGISTER
Jan 16, 2018 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 9, 2017 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 8, 2017 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 7, 2017 EXRA
EXAMINER'S AMENDMENT ENTERED
Dec 6, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 6, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 6, 2017 GNEA
SU-EXAMINER'S AMENDMENT WRITTEN
Dec 6, 2017 SNEA
STATEMENT OF USE PROCESSING COMPLETE
Dec 6, 2017 SUPC
SOU EXTENSION 1 GRANTED
Dec 6, 2017 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 6, 2017 AITU
USE AMENDMENT FILED
Nov 30, 2017 IUAF
SOU EXTENSION 1 FILED
Nov 30, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 30, 2017 EEXT
TEAS STATEMENT OF USE RECEIVED
Nov 30, 2017 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 30, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 4, 2017 NPUB
PUBLISHED FOR OPPOSITION
Apr 4, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 15, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 28, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 22, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 22, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 22, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 22, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 22, 2017 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Feb 15, 2017 ZZZX
WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST
Nov 14, 2016 PBMR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 4, 2016 PREV
ASSIGNED TO LIE
Oct 28, 2016 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 14, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 14, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 13, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 13, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 16, 2016 GNRN
NON-FINAL ACTION E-MAILED
Sep 16, 2016 GNRT
NON-FINAL ACTION WRITTEN
Sep 16, 2016 CNRT
ASSIGNED TO EXAMINER
Sep 15, 2016 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 11, 2016 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 10, 2016 NWOS
NEW APPLICATION ENTERED
Jun 7, 2016 NWAP

Related Trademarks

More from this Owner

MEKTOVI

MEKTOVI

MEKTOVI

MEKTOVI

MEKTOVI

MEKTOVI

MEKTOVI

MEKTOVI

MEKTOVI

MEKTOVI

MEKTOVI

MEKTOVI